(Q33373387)

26 July 2017

Angiokeratomas of Fabry successfully treated with intense pulsed light (English)

1 reference

26 July 2017

Alberto Vieira Mota

4

0 references

João Paulo Oliveira

object named as

João Paulo Oliveira

5

0 references

author name string

Paulo Morais

1

1 reference

26 July 2017

António Luís Santos

2

1 reference

26 July 2017

Teresa Baudrier

3

1 reference

26 July 2017

Filomena Azevedo

6

1 reference

26 July 2017

language of work or name

1 reference

1 December 2008

1 reference

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology

26 July 2017

1 reference

26 July 2017

10

1 reference

26 July 2017

4

1 reference

26 July 2017

218-222

1 reference

Prevalence of lysosomal storage disorders

26 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Neurological manifestations in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

High incidence of later-onset fabry disease revealed by newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

A CASE OF “ANGEIO-KERATOMA.”

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Natural history of Fabry disease in females in the Fabry Outcome Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

New developments in the management of Anderson-Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Narrative review: Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease and the skin: data from FOS, the Fabry outcome survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease: recognition and management of cutaneous manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Emerging strategies for the treatment of hereditary metabolic storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

Maladie de Fabry - Place du dermatologue et progrès thérapeutiques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14764170802275832

10.1080/14764170802275832

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference